REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA

This adverse event was reported 102 times

These drugs are most commonly taken by patients reporting REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA:

# Drug Count
0 CYCLOPHOSPHAMIDE 44
1 CYCLOPHOSPHAMIDE FOR INJECTION 44
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 44
3 DEXAMETHASONE 36
4 DEXAMETHASONE 1.5 MG 36
5 LENALIDOMIDE 33
6 MELPHALAN HYDROCHLORIDE 27
7 MELPHALAN 21
8 FLUDARABINE PHOSPHATE 20
9 RITUXIMAB 16
See all common drugs associated with REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA

REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CARMUSTINE 8 0.0017
1 IBRITUMOMAB TIUXETAN 2 0.0013
2 MITOXANTRONE HYDROCHLORIDE 7 0.0011
3 MELPHALAN HYDROCHLORIDE 27 0.0011
4 SODIUM IODIDE I 123 1 0.0011
5 SODIUM IODIDE I 131 1 0.0010
6 VINBLASTINE SULFATE 2 0.0010
7 CLADRIBINE 6 0.0006
8 ROMIDEPSIN 1 0.0006
9 SARGRAMOSTIM 1 0.0006
See all drugs enriched for association with REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA